| 1 |
35241643 | miR-146a impedes the anti-aging effect of AMPK via NAMPT suppression and NAD+/SIRT inactivation. | 2022 Mar 4 |
1 |
| 2 |
31920356 | Differential Expression of Human N-Alpha-Acetyltransferase 40 (hNAA40), Nicotinamide Phosphoribosyltransferase (NAMPT) and Sirtuin-1 (SIRT-1) Pathway in Obesity and T2DM: Modulation by Metformin and Macronutrient Intake. | 2019 |
1 |
| 3 |
27813052 | Effects of Metformin on Endocrine and Metabolic Parameters in Patients with Polycystic Ovary Syndrome. | 2017 Feb |
1 |
| 4 |
26473366 | Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis. | 2015 |
2 |
| 5 |
24874591 | Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients. | 2014 Jul |
1 |
| 6 |
23315983 | Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis. | 2013 May |
3 |
| 7 |
23061989 | A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function. | 2012 Dec |
1 |
| 8 |
19111298 | Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome. | 2010 Feb |
3 |
| 9 |
21126943 | Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome. | 2010 Dec |
2 |
| 10 |
18778865 | The effects of pioglitazone and metformin on plasma visfatin levels in patients with treatment naive type 2 diabetes mellitus. | 2008 Nov |
1 |
| 11 |
19888409 | Impact of treatment with rosiglitazone or metformin on biomarkers for insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. | 2007 Mar |
1 |